CIS Launches New Educational Program through Participation in Three Regional BIO Events
CIS' educational program offers a variety of topics on clinical compliance and commercial issues facing emerging and small biopharm organizations.
- Raleigh-Durham-Chapel Hill, NC (1888PressRelease) September 20, 2012 - Compliance Implementation Services (CIS), a leading life sciences consulting firm, today announced the launch of a new program providing executive-level educational workshops through its participation in three premier regional events for the biotech industry-BioPharm America (September 19-21), Mid-Atlantic Bio Conference (September 27-28), and Biotech 2012: Find. Fund. Facilitate (October 22).
CIS' educational program covers a wide variety of topics on clinical compliance and commercial issues facing emerging and small biopharm organizations. The topics-which range from clinical vendor oversight, to building a compliance program, contracting strategies, and government program market access-educate executives on the processes needed for a compliant business and the options available for commercial success.
The workshops also address a growing trend in which emerging companies are determining that a large pharma partner is not necessarily required for success in the US market and are pursuing their own commercialization strategies. "For executives who are considering in-house or out-sourced commercialization, it's important to have baseline knowledge of clinical and commercial compliance requirements, contracting strategies, and Government Programs participation.
CIS' educational workshops provide this insight while explaining the commercialization options, activities, and associated risks, all within a timeline format that helps executives understand what they need to know, when they need to know it," said Chris Cobourn, Senior Vice President, Commercial Compliance at CIS. "We are pleased to offer this opportunity to educate executives and to help them in furthering their business goals."
CIS' participation in BioPharm America, Mid-Atlantic Bio, and Biotech 2012 builds on the firm's strategic affiliation with regional BIO groups that support the firm's clients. CIS is a member of the Massachusetts Biotechnology Council,
Pennsylvania BIO, and San Francisco-based BayBio and plans to expand its BIO presence and memberships in 2013 to further support its growing client base on the East and West Coasts.
About Compliance Implementation Services (CIS)
Compliance Implementation Services (CIS) is a leading life sciences consulting firm specializing in compliance strategies for pharmaceutical, biotech, and medical device companies, from clinical, through manufacturing, commercial contracting, commercial compliance, and Government Programs.
CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to guide them to a better "Culture of Compliance" that is meaningful and sustainable. For more information, visit www.cis-partners.com.
About BioPharm America, Mid-Atlantic Bio, and Biotech 2012
These regional BIO conferences are the foremost biotech business events for senior-level executives, financiers, academia, media, and service providers. Over the course of six days, nearly 3,000 bioscience leaders from around the world will network, connect with potential partners, share business strategies, and learn from their peers.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam